Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression

Background. Dengue virus (DENV) infection is the most common arboviral disease that affects tropical and subtropical regions. Based on the clinical hallmarks, the different severities of patients range from mild dengue fever (MDF) to severe dengue diseases (SDDs) and include dengue hemorrhagic fever...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Josephine Diony Nanda, Chiau-Jing Jung, Rahmat Dani Satria, Ming-Kai Jhan, Ting-Jing Shen, Po-Chun Tseng, Yung-Ting Wang, Tzong-Shiann Ho, Chiou-Feng Lin
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/30614651fdba4b30bbea58052353cb3a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:30614651fdba4b30bbea58052353cb3a
record_format dspace
spelling oai:doaj.org-article:30614651fdba4b30bbea58052353cb3a2021-11-08T02:36:57ZSerum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression2314-715610.1155/2021/7652569https://doaj.org/article/30614651fdba4b30bbea58052353cb3a2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/7652569https://doaj.org/toc/2314-7156Background. Dengue virus (DENV) infection is the most common arboviral disease that affects tropical and subtropical regions. Based on the clinical hallmarks, the different severities of patients range from mild dengue fever (MDF) to severe dengue diseases (SDDs) and include dengue hemorrhagic fever or dengue shock syndrome. These are commonly associated with cytokine release syndrome (CRS). The types and levels of cytokines/chemokines, which are suppressed or enhanced, are varied, indicating CRS’s pathogenic and host defensive effects. Principal Finding. In this study, we created an integrated and precise multiplex panel of cytokine/chemokine assays based on our literature analysis to monitor dengue CRS. A 24-plex panel of cytokines/chemokines was evaluated to measure the plasma levels of targeting factors in dengue patients with an MDF and SDD diagnosis without or with comorbidities. As identified in sixteen kinds of cytokines/chemokines, ten were significantly (P<0.05) (10/16) increased, one was significantly (P<0.01) (1/16) decreased, and five were potentially (5/16) altered in all dengue patients (n=30) in the acute phase of disease onset. Compared to MDF, the levels of IL-8 (CXCL-8) and IL-18 in SDD were markedly (P<0.05) increased, accompanied by positively increased IL-6 and TNF-α and decreased IFN-γ and RANTES. With comorbidities, SDD significantly (P<0.01) portrayed elevated IL-18 accompanied by increased IL-6 and decreased IFN-α2 and IL-12. In addition, decreased platelets were significantly (P<0.05) associated with increased IL-18. Significance. These results demonstrate an efficient panel of dengue cytokine/chemokine assays used to explore the possible level of CRS during the acute phase of disease onset; also, we are the first to report the increase of IL-18 in severe dengue with comorbidity compared to severe dengue without comorbidity and mild dengue.Josephine Diony NandaChiau-Jing JungRahmat Dani SatriaMing-Kai JhanTing-Jing ShenPo-Chun TsengYung-Ting WangTzong-Shiann HoChiou-Feng LinHindawi LimitedarticleImmunologic diseases. AllergyRC581-607ENJournal of Immunology Research, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
spellingShingle Immunologic diseases. Allergy
RC581-607
Josephine Diony Nanda
Chiau-Jing Jung
Rahmat Dani Satria
Ming-Kai Jhan
Ting-Jing Shen
Po-Chun Tseng
Yung-Ting Wang
Tzong-Shiann Ho
Chiou-Feng Lin
Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression
description Background. Dengue virus (DENV) infection is the most common arboviral disease that affects tropical and subtropical regions. Based on the clinical hallmarks, the different severities of patients range from mild dengue fever (MDF) to severe dengue diseases (SDDs) and include dengue hemorrhagic fever or dengue shock syndrome. These are commonly associated with cytokine release syndrome (CRS). The types and levels of cytokines/chemokines, which are suppressed or enhanced, are varied, indicating CRS’s pathogenic and host defensive effects. Principal Finding. In this study, we created an integrated and precise multiplex panel of cytokine/chemokine assays based on our literature analysis to monitor dengue CRS. A 24-plex panel of cytokines/chemokines was evaluated to measure the plasma levels of targeting factors in dengue patients with an MDF and SDD diagnosis without or with comorbidities. As identified in sixteen kinds of cytokines/chemokines, ten were significantly (P<0.05) (10/16) increased, one was significantly (P<0.01) (1/16) decreased, and five were potentially (5/16) altered in all dengue patients (n=30) in the acute phase of disease onset. Compared to MDF, the levels of IL-8 (CXCL-8) and IL-18 in SDD were markedly (P<0.05) increased, accompanied by positively increased IL-6 and TNF-α and decreased IFN-γ and RANTES. With comorbidities, SDD significantly (P<0.01) portrayed elevated IL-18 accompanied by increased IL-6 and decreased IFN-α2 and IL-12. In addition, decreased platelets were significantly (P<0.05) associated with increased IL-18. Significance. These results demonstrate an efficient panel of dengue cytokine/chemokine assays used to explore the possible level of CRS during the acute phase of disease onset; also, we are the first to report the increase of IL-18 in severe dengue with comorbidity compared to severe dengue without comorbidity and mild dengue.
format article
author Josephine Diony Nanda
Chiau-Jing Jung
Rahmat Dani Satria
Ming-Kai Jhan
Ting-Jing Shen
Po-Chun Tseng
Yung-Ting Wang
Tzong-Shiann Ho
Chiou-Feng Lin
author_facet Josephine Diony Nanda
Chiau-Jing Jung
Rahmat Dani Satria
Ming-Kai Jhan
Ting-Jing Shen
Po-Chun Tseng
Yung-Ting Wang
Tzong-Shiann Ho
Chiou-Feng Lin
author_sort Josephine Diony Nanda
title Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression
title_short Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression
title_full Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression
title_fullStr Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression
title_full_unstemmed Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression
title_sort serum il-18 is a potential biomarker for predicting severe dengue disease progression
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/30614651fdba4b30bbea58052353cb3a
work_keys_str_mv AT josephinedionynanda serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
AT chiaujingjung serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
AT rahmatdanisatria serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
AT mingkaijhan serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
AT tingjingshen serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
AT pochuntseng serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
AT yungtingwang serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
AT tzongshiannho serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
AT chioufenglin serumil18isapotentialbiomarkerforpredictingseveredenguediseaseprogression
_version_ 1718443077594513408